TABLE 1.
List of Neurodegenerative Diseases That Can Be Impacted by Cell-and/or Gene-Based Therapies
| Disease | Underlying Cause | Potential Treatment Strategy |
|---|---|---|
| PD | Death of dopaminergic neurons | Transplantation of dopaminergic neurons derived from ESC/iPS cells |
| Stroke | Neuronal death | Cell replacement with fully functional neurons derived from ESC/iPS cells |
| ALS | Loss of motor neurons | Cell therapy based on motor neurons derived from ESC/iPS cells |
| SMA | Spinal motor neuron death | Drug screening based on in vitro models of NPs/iPS cells for SMA; generation of spinal motor neurons from iPS cells |
| HD | Death of neurons in the striatum | Cell replacement with striatal neurons derived from iPS cells |
| AD | Loss of neurons and synapses throughout the brain | Drug screening based on in vitro models of AD; gene and cell therapy: transplantation of cells that overexpress NGF |
| MS | Immune system attacking myelin sheaths | Cell therapy based on transplantation of oligodendrocytes derived from ESC/iPS cells; autologous stem cell transplantation to repopulate the immune system |
iPS, induced pluripotent stem